Last Week’s Top-3 Most Read Posts On Pulmonary Fibrosis

Written by Marta Ribeiro |

pftop3

1. Esbriet’s Promise and Potential as a PF Therapy

2. IPF Experts Discuss Disease Diagnosis and Treatment at CHEST 2015

3. Boehringer Ingelheim’s OFEV (Nintedanib) IPF Therapy Reinforces Efficacy and Safety Profile in New Studies